Authors
Xintong Wang, Wenjie Hu, Xiaohui Cheng, Jie Zhu, Weiming Zhu, Junfeng Zhang, Yi Li, Zhen Huang, Jiangning Chen
Published in
Cellular and molecular gastroenterology and hepatology. Pages 101930. Nov 14, 2026. Epub Nov 14, 2026.
Abstract
Intestinal fibrosis is a common and intractable complication of Crohn's disease (CD) that leads to strictures and often requires surgery. Although epithelial-mesenchymal transition (EMT) drives this process, the roles of epithelial-derived microRNAs during EMT remain poorly defined. We aimed to define the function of miR-215-5p/3p in EMT and evaluate their therapeutic potential in established intestinal fibrosis.
Using human fibrostenotic CD tissues and a TNBS-induced murine colitis model, we identified epithelial-enriched miRNAs by small RNA sequencing, qRT-PCR, in situ hybridization, and magnetic cell sorting. Mechanistic studies used bioinformatics, luciferase assays, DNA pull-down, mass spectrometry, CUT&RUN, EMSA, patient-derived intestinal organoids, and loss- and gain-of-function experiments. The antifibrotic effects of combined agomiR-215-5p/3p were evaluated by histology, collagen quantification, and EMT marker analysis.
miR-215-5p/3p were among the most downregulated epithelial-enriched miRNAs in fibrotic tissues, and their reduction correlated with disease progression and EMT activation in human CD strictures and murine fibrosis. Restoring miR-215-5p/3p in patient-derived intestinal organoids suppressed EMT and fibroblast activation under fibrogenic conditions. Mechanistically, miR-215-5p and miR-215-3p directly targeted the 3'UTRs of ZEB2 and STC1, respectively, and their expression was transcriptionally activated by CREB1, which was downregulated in CD strictures. In vivo, combined agomiR-215-5p/3p reduced colonic hydroxyproline content by ∼55.6% and collagen deposition by ∼47.7%, reversed EMT markers, and attenuated established fibrosis. ZEB2 or STC1 re-expression with mutant 3'UTRs abolished these effects, while miR-215-5p/3p inhibition exacerbated TNBS-induced fibrosis.
We identified a CREB1-miR-215-5p/3p-ZEB2/STC1 axis in intestinal fibrosis, elucidating a mechanism of epithelial-mesenchymal reprogramming and supporting miRNA replacement therapy for CD strictures.
PMID:
43033868
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0